Interferon-γ-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase
Interferon-γ-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase
复制标题
通过抑制 mTOR 和 HMG-CoA 还原酶,干扰素 γ 诱导的内皮细胞上的 HLA II 类表达降低
DOI:
10.1002/2211-5463.12854
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Kobayashi T
中科院分区:
文献类型:
--
作者:
Maenaka A;Kenta I;Ota A;Miwa Y;Ohashi W;Horimi K;Matsuoka Y;Ohnishi M; Uchida K;Kobayashi T
In organ transplantation, donor‐specific HLA antibody (DSA) is considered a major cause of graft rejection. Because DSA targets primarily donor‐specific human leukocyte antigen (HLA) expressed on graft endothelial cells, the prevention of its expression is a possible strategy for avoiding or salvaging DSA‐mediated graft rejection. We examined the effect of various clinically used drugs on HLA class II expression on endothelial cells. Interferon‐γ (IFN‐γ)‐induced HLA class II DR (HLA‐DR) was downregulated by everolimus (EVR, 49.1% ± 0.8%;P< 0.01) and fluvastatin (FLU, 33.8% ± 0.6%;P< 0.01). Moreover, the combination of EVR and FLU showed a greater suppressive effect on HLA‐DR expression. In contrast, cyclosporine, tacrolimus, mycophenolic acid, and prednisolone did not exhibit any significant suppressive effect. FLU, but not EVR, suppressed mRNA of HLA‐DR. Imaging analysis revealed that HLA‐DR expressed in cytosol or on the cell surface was repressed by EVR (cytosol: 58.6% ± 4.9%,P< 0.01; cell surface: 80.9% ± 4.0%,P< 0.01) and FLU (cytosol: 19.0% ± 3.4%,P< 0.01; cell surface: 48.3% ± 4.8%,P< 0.01). These data indicated that FLU and EVR suppressed IFN‐γ‐induced HLA‐DR expression at the transcriptional and post‐translational level, respectively, suggesting a potential approach for alleviating DSA‐related issues in organ transplantation.